history of glp-1 drugs Continued growth for receptor agonists and SGLT-2 inhibitors in 2017 Complete Guide to GLP-1 Medications
Description
doi: 10.1681/ASN.2013101067
In the cardiovascular system, GLP-1R engagement exerts cardioprotective effects and attenuates systemic inflammation
These drugs mimic GLP-1s effects, slowing digestion, reducing appetite, and helping people control blood sugar and weight
participants aged 18 years who were overweight or have obesity, defined as having a BMI 25 kg/m 2 (or 23 kg/m 2 for Japanese and 24 kg/m2 for Chinese) [4]
J Clin Endocrinol Metab 2011;96:13011310
